An Overview of the Challenging Process of Prior Authorization: Medical Necessity for a Better Way
- PMID: 39303798
- PMCID: PMC11604005
- DOI: 10.1016/j.cgh.2024.09.001
An Overview of the Challenging Process of Prior Authorization: Medical Necessity for a Better Way
Conflict of interest statement
Conflicts of interest
These authors disclose the following: Stephen T. Amann has been ad hoc consultant for Eli Lilly. Eric D. Shah consulted for Ardelyx, Mahana, Mylan, Neuraxis, Sanofi, Salix, and Takeda. The remaining author discloses no conflicts.
References
-
- Sofia MA, Feuerstein JD, Narramore L, et al. White Paper: American Gastroenterology Association Positions Statement: the future of IBD care in the United States–removing barriers and embracing opportunities. Clin Gastroenterol Hepatol 2024; 22:944–955. - PubMed
-
- Brot-Goldberg ZC, Burn S, Layton T, et al. Rationing medicine through bureaucracy: authorization restrictions in Medicare. Cambridge, MA: National Bureau of Economic Research, January 2023. Available at: https://www.nber.org/papers/w30878. Accessed February 18, 2024.
-
- Grimm CA. Some Medicare Advantage Organization Denials of Prior Authorization Requests Raise Concerns About Beneficiary Access to Medically Necessary Care. OEI-09-18-00260. Available at: https://oig.hhs.gov/oei/reports/OEI-09-18-00260.asp. Accessed February 21, 2024.
Grants and funding
LinkOut - more resources
Full Text Sources